- Home
- MOS vs MEDP Comparison
MOS vs MEDP Comparison
Compare MOS & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOS
- MEDP
- Stock Information
- Founded
- MOS 1987
- MEDP 1992
- Country
- MOS United States
- MEDP United States
- Employees
- MOS N/A
- MEDP N/A
- Industry
- MOS Agricultural Chemicals
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- MOS Industrials
- MEDP Health Care
- Exchange
- MOS Nasdaq
- MEDP Nasdaq
- Market Cap
- MOS 8.6B
- MEDP 8.3B
- IPO Year
- MOS 2004
- MEDP 2016
- Fundamental
- Price
- MOS $36.79
- MEDP $297.81
- Analyst Decision
- MOS Buy
- MEDP Hold
- Analyst Count
- MOS 12
- MEDP 10
- Target Price
- MOS $34.83
- MEDP $343.22
- AVG Volume (30 Days)
- MOS 5.2M
- MEDP 327.9K
- Earning Date
- MOS 05-06-2025
- MEDP 07-21-2025
- Dividend Yield
- MOS 2.40%
- MEDP N/A
- EPS Growth
- MOS N/A
- MEDP 33.36
- EPS
- MOS 1.15
- MEDP 13.09
- Revenue
- MOS $11,064,300,000.00
- MEDP $2,156,580,000.00
- Revenue This Year
- MOS $17.87
- MEDP $5.59
- Revenue Next Year
- MOS N/A
- MEDP $3.46
- P/E Ratio
- MOS $31.30
- MEDP $22.76
- Revenue Growth
- MOS N/A
- MEDP 9.87
- 52 Week Low
- MOS $22.36
- MEDP $250.05
- 52 Week High
- MOS $36.89
- MEDP $459.77
- Technical
- Relative Strength Index (RSI)
- MOS 80.99
- MEDP 48.75
- Support Level
- MOS $35.63
- MEDP $293.51
- Resistance Level
- MOS $36.21
- MEDP $302.32
- Average True Range (ATR)
- MOS 0.80
- MEDP 8.85
- MACD
- MOS -0.03
- MEDP -0.19
- Stochastic Oscillator
- MOS 97.39
- MEDP 42.94
About MOS Mosaic Company (The)
Mosaic is one of the largest phosphate and potash producers in the world. The company's assets include phosphate rock mines in Florida, Brazil, and Peru and potash mines in Saskatchewan, New Mexico, and Brazil. Mosaic also runs a large fertilizer distribution operation in Brazil through its Mosaic Fertilizantes business.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the US, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.